This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Colin Sauder
Director and Clinical Scientist at Karuna Therapeutics


Colin is a director and clinical scientist at Karuna Therapeutics, a biotech committed on bringing novel therapeutics to market in CNS. In his role as clinical scientist, Colin supports Karuna’s ongoing Phase 3 development program in schizophrenia. He is particularly focused on the integration of digital technology in clinical trials to improve outcome assessment and mitigate risk. Before joining Karuna, Colin was a principal investigator and clinical director at a private research site. Prior to joining industry, he held a tenure-track position in the psychiatry department at UT Health San Antonio.

Agenda Sessions

  • Validation and Process Challenges and Solutions Caused by the Pandemic